SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-21-200438
Filing Date
2021-06-25
Accepted
2021-06-25 16:29:30
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d185045ds3.htm S-3 202068
2 EX-5.1 d185045dex51.htm EX-5.1 9552
3 EX-10.1 d185045dex101.htm EX-10.1 199345
4 EX-23.1 d185045dex231.htm EX-23.1 1421
5 GRAPHIC g185045dsp28.jpg GRAPHIC 3740
6 GRAPHIC g185045g34s03.jpg GRAPHIC 30739
  Complete submission text file 0001193125-21-200438.txt   456340
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-257422 | Film No.: 211048275
SIC: 2836 Biological Products, (No Diagnostic Substances)